Standard Operating Procedure for Regulatory Intelligence Monitoring and Reporting

Department	Regulatory Affairs
SOP No.	RA/2026/624
Supersedes	NA
Page No.	1 of X
Issue Date	08/04/2026
Effective Date	08/04/2026
Review Date	08/04/2028

Purpose

This Standard Operating Procedure (SOP) describes the systematic process for monitoring, collecting, analyzing, and reporting regulatory intelligence relevant to the pharmaceutical industry. It ensures timely awareness and compliance with evolving regulatory requirements to support informed decision-making and to maintain alignment with global and local regulatory authorities. The objective is to establish control measures that reduce regulatory risks, maintain audit readiness, and facilitate continuous regulatory compliance across all impacted functional units.

Scope

This SOP applies to all regulatory affairs personnel responsible for intelligence gathering, analysis, and communication within the regulatory intelligence function. It covers monitoring regulatory news, updates, guidelines, policies, and changes from global and regional health authorities applicable to pharmaceutical products, dosage forms, manufacturing processes, validation, quality systems, documentation, and related regulatory submissions. The SOP excludes direct regulatory submission writing activities and specific validation or calibration procedures, which are governed by separate SOPs.

Responsibilities

The following roles are involved in the execution and oversight of this SOP:

• Regulatory Intelligence Analyst – responsible for monitoring regulatory sources, gathering data, and preliminary analysis.
• Regulatory Affairs Manager – reviews and verifies the regulatory intelligence reports for accuracy and completeness.
• Quality Compliance Officer – ensures that the regulatory updates are communicated effectively for compliance across departments.
• Document Control Coordinator – manages documentation, version control, and record retention of intelligence reports.

Accountability

The Head of Regulatory Affairs holds accountability for the implementation, compliance, periodic review, escalation of issues, and assessing the SOP’s effectiveness. This role ensures regulatory intelligence activities are aligned with corporate quality policies and applicable regulatory standards.

Procedure

1. Preparation and Prerequisites:

Ensure access to relevant regulatory authority websites, subscription services, databases, and published guidelines. Confirm training in regulatory intelligence and compliance requirements for involved personnel.

2. Monitoring and Data Collection:

Collect regulatory intelligence by systematically scanning updates from appropriate authorities such as FDA, EMA, ICH, WHO, and local agencies. Utilize automated alerts, newsletters, and agency bulletins to capture changes, new guidances, and enforcement trends.

3. Initial Review and Classification:

Analyze collected information to determine relevance to corporate products, processes, and quality systems. Classify intelligence by type, priority, and impacted functions.

4. Reporting and Communication:

Prepare standardized regulatory intelligence reports including summary of change, impact assessment, proposed actions, and effective dates. Submit reports for supervisory review within defined timelines.

5. Verification and Approval:

The Regulatory Affairs Manager reviews and approves the intelligence reports, verifying for accuracy and required follow-up actions. Incorporate feedback and finalize documentation.

6. Dissemination and Follow-up:

Communicate approved reports to affected departments including Quality, Manufacturing, Engineering, and Documentation teams. Coordinate necessary compliance actions, training, or procedure updates arising from new regulatory information.

7. Documentation and Record Keeping:

Maintain all intelligence reports, supporting documents, and communication records in a controlled documentation system with appropriate version control and retention as per quality policy. Ensure traceability for audits and inspections.

8. Deviations and Escalations:

Identify and document any deviations or delays in monitoring or reporting processes. Escalate critical regulatory changes or compliance risks to senior management immediately.

9. Periodic Review and Continuous Improvement:

Conduct periodic reviews of the regulatory intelligence process to evaluate effectiveness, update procedures, and incorporate lessons learned to improve monitoring accuracy and response time.

Abbreviations

RA – Regulatory Affairs
FDA – Food and Drug Administration
EMA – European Medicines Agency
ICH – International Council for Harmonisation
WHO – World Health Organization
SOP – Standard Operating Procedure

Documents

Relevant documents required for execution of this SOP include:

1. Regulatory Intelligence Report Template (Annexure-1)
2. Regulatory Sources and Monitoring Checklist (Annexure-2)
3. Regulatory Intelligence Communication Log (Annexure-3)

References

1. FDA Guidance for Industry – Compliance and Regulatory Information
2. EMA Regulatory Science Strategy
3. ICH Q9 – Quality Risk Management
4. WHO GMP Guidelines
5. Corporate Quality Management System Documentation and Policies

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Regulatory Intelligence Report Template

Purpose: To document and summarize regulatory intelligence findings, assessments, and recommended actions.

Report ID	RI-20260408-001
Date of Report	08/04/2026
Monitored Source	FDA Website – Guidance Update
Summary of Update	New guidance on validation of computerized systems released.
Impact Assessment	Requires revision of validation procedures in IT and QA departments.
Proposed Actions	Initiate cross-functional review and update applicable SOPs within 30 days.
Effective Date	01/07/2026
Prepared By
Reviewed By
Approved By

Annexure-2: Regulatory Sources and Monitoring Checklist

Purpose: To provide a comprehensive list of regulatory sources with scheduled monitoring frequency to ensure thorough and consistent intelligence gathering.

Regulatory Authority / Source	URL / Access Method	Monitoring Frequency	Responsible Person	Last Monitored Date
FDA	https://www.fda.gov	Weekly	Regulatory Intelligence Analyst	04/04/2026
EMA	https://www.ema.europa.eu	Bi-weekly	Regulatory Intelligence Analyst	01/04/2026
ICH	https://www.ich.org	Monthly	Regulatory Intelligence Analyst	31/03/2026
WHO	https://www.who.int/medicines	Monthly	Regulatory Affairs Manager	31/03/2026

Annexure-3: Regulatory Intelligence Communication Log

Purpose: To record dissemination and acknowledgements of regulatory intelligence information to impacted departments ensuring traceability and accountability.

Communication ID	Date	Report ID	Departments Notified	Mode of Communication	Acknowledgement Status	Remarks
COM-20260408-001	08/04/2026	RI-20260408-001	Quality Assurance, Manufacturing, Documentation	Email	Received	Follow-up training scheduled
COM-20260401-002	01/04/2026	RI-20260401-005	Regulatory Affairs, Compliance	Intranet Post	Pending	Reminder sent

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
08/04/2026	1.0	Initial issue	New SOP creation